swine
testi
st
cell
cultur
treat
variou
dose
recombin
human
interferonalpha
ifn
assay
oligoadenyl
synthetas
synthetas
activ
treatment
unitsml
ifn
result
increas
synthetas
activ
signific
respons
unitml
ifn
titr
porcin
transmiss
gastroenter
viru
tgev
reduc
hour
postinfect
st
cell
treat
unitsml
ifn
polyacrylamid
gel
electrophoresi
lysat
tgevinfect
st
cell
lysat
immunoprecipit
antitgev
antibodi
reveal
synthesi
n
protein
tgev
reduc
cell
treat
unitsml
ifn
viral
rna
product
determin
probe
hybrid
gene
tgev
found
reduc
st
cell
treat
unitsml
ifn
cell
treat
unitsml
conclud
ifntreat
st
cell
tgev
protein
product
may
decreas
absenc
reduc
viral
rna
product
synthetas
may
signific
factor
antivir
activ
ifn
tgev
well
establish
replic
transmiss
gastroenter
viru
tgev
porcin
enter
coronaviru
may
inhibit
treatment
interferon
ifn
alpha
thu
natur
porcin
ifnqlpha
found
reduc
yield
tgev
swine
testi
st
cell
porcin
enterocyt
weingartl
derbyshir
similarli
antivir
effect
recombin
human
ifnalpha
demonstr
tgev
st
cell
jordan
derbyshir
inform
lack
howev
mechan
antivir
action
ifnalpha
tgev
coronavirus
mani
virus
consist
characterist
ifninduc
antivir
state
reduct
viral
protein
synthesi
interferon
induc
number
cellular
protein
sen
ransohoff
includ
oligoadenyl
synthetas
synthetas
studi
extens
shown
major
contributor
ifninduc
antivir
state
least
relat
picomaviru
infect
samuel
antivir
effect
synthetas
depend
upon
abil
catalys
synthesi
oligoadenyl
activ
latent
endonucleas
degrad
viral
messeng
rna
therefor
inhibit
viral
protein
synthesi
recombin
bovin
ifnalpha
induc
dosedepend
increas
synthetas
st
cell
infect
neonat
pig
tgev
caus
signific
increas
enterocyt
synthetas
activ
bosworth
et
al
role
synthetas
antivir
activ
ifnalpha
coronavirus
unknown
object
present
studi
investig
synthetas
activ
synthesi
viral
protein
rna
antivir
state
induc
ifn
tgev
st
cell
treat
variou
concentr
human
recombin
ifnalpha
shown
close
relat
antigen
porcin
leukocyt
ifn
karayiannivasconcelo
et
al
antivir
effect
tgev
st
cell
jordan
derbyshir
treat
cell
monitor
synthetas
activ
infect
tgev
stage
infecti
cycl
inhibit
ifn
determin
viral
protein
product
ifn
treat
st
cell
examin
radiolabel
immunoprecipit
viral
rna
product
examin
probe
lysat
infect
cell
radiolabel
tgev
gene
fragment
human
recombin
obtain
commerci
sourc
roferon
hoffmanla
roch
antivir
activ
determin
plaqu
reduct
assay
madindarbi
bovin
kidney
cell
challeng
vesicular
stomat
viru
previous
describ
loewen
derbyshir
st
cell
mcclurkin
norman
grown
confluenc
nunclon
six
well
tissu
cultur
dish
nunc
eagl
minimum
essenti
medium
emem
supplement
neonat
calf
serum
nnc
cell
treat
hour
unit
ifn
dilut
emem
nnc
activ
synthetas
treat
cell
assay
describ
bielefeldtohmann
et
al
briefli
st
cell
pellet
lyse
cell
extract
incub
poli
rc
agaros
bead
bead
incub
reaction
mixtur
contain
label
atp
termin
reaction
alkalin
phosphatas
bead
pellet
supemat
appli
acid
alumina
column
phosphataseresist
oligoadenyl
elut
column
radionuclid
incorpor
enumer
liquid
scintil
count
mean
standard
deviat
count
per
min
per
x
cell
calcul
differ
mean
yield
analys
use
valu
follow
fisherbehren
distribut
campbel
st
cell
grown
confluenc
nunclon
six
well
tissu
cultur
dish
treat
unitsml
ifn
hour
cell
infect
miller
strain
tgev
welch
saif
obtain
dr
lj
saif
ohio
state
univers
multipl
infect
moi
adsorpt
min
inoculum
remov
cell
wash
phosphat
buffer
salin
pb
replac
mlwell
emem
contain
nnc
hepe
buffer
supernat
collect
interv
subsequ
assay
viru
plaqu
format
st
cell
mean
standard
deviat
viru
yield
express
log
pfuml
calcul
differ
mean
yield
analys
use
valu
follow
fisherbehren
distribut
campbel
effect
ifn
treatment
tgev
protein
product
examin
radiolabel
protein
produc
infect
st
cell
fourdayold
monolay
st
cell
grown
six
well
nunclon
tissu
cultur
dish
treat
mlwell
emem
nnc
contain
unitsml
ifn
two
well
per
plate
hour
cell
wash
twice
pb
inocul
mlwell
miller
tgev
emem
moi
emem
alon
viru
allow
adsorb
min
inoculum
remov
plate
wash
pb
emem
contain
nnc
ad
plate
radiolabel
done
hour
postinfect
hpi
ziml
methionin
gil
mmol
icn
biomed
canada
ltd
follow
hour
starvat
period
methioninefre
emem
supplement
methioninefre
nnc
label
cell
wash
pb
lyse
lysi
buffer
mm
nacl
sodium
deoxychol
triton
sodium
dodecyl
sulphat
sd
mm
tri
hcl
ph
lysat
store
cultur
supernat
collect
assay
viru
concentr
plaqu
format
one
hundr
radiolabel
cell
lysat
incub
room
temperatur
min
polyclon
antitgev
porcin
antiserum
rais
pig
infect
oral
dose
ambico
vaccin
strain
tgev
subsequ
intramuscular
inject
attenu
purdu
strain
viru
kindli
provid
dr
tama
tuboli
univers
guelph
suspens
formalinfix
staphylococcu
aureu
pansorbin
cell
calbiochem
corp
complex
pellet
wash
sequenti
wash
buffer
nacl
sodium
deoxychol
triton
sd
tri
hcl
ph
b
nacl
tri
hcl
ph
c
nacl
mm
edta
tri
hci
sd
ph
resuspend
electrophoresi
sampl
buffer
esb
trishcl
ph
sd
glycerol
bromophenol
blue
boil
min
cell
debri
remov
centrifug
supernat
store
whole
cell
lysat
immunoprecipit
examin
sdspolyacrylamid
gel
electrophoresi
page
use
method
laemmli
sampl
dilut
esb
separ
electrophoresi
volt
polyacrylamid
gel
contain
sd
gel
fix
treat
autoradiographi
enhanc
du
pont
canada
inc
accord
manufactur
instruct
expos
kodak
xomat
ar
rp
radiograph
film
baculoviru
transfer
vector
contain
cdna
copi
kb
end
gene
encod
protein
attenu
purdu
strain
tgev
tuboli
et
al
obtain
dr
tama
tuboli
univers
guelph
kb
fragment
remov
vector
digest
bamhl
ecorl
restrict
endonucleas
separ
electrophoresi
agaros
gel
fragment
extract
agaros
radiolabel
pci
dctp
cimmol
icn
biomed
canada
ltd
use
random
primer
label
system
brl
life
technolog
inc
fivedayold
monolay
st
cell
treat
hour
unit
ml
ifn
infect
miller
strain
tgev
moi
hour
postinfect
cultur
supernat
collect
viru
assay
plaqu
format
lysat
infect
cell
use
rna
hybrid
prepar
follow
cell
wash
twice
cold
pb
scrape
ml
pb
pellet
centrifug
second
pellet
resuspend
te
buffer
ph
nonidet
sigma
chemic
co
cell
place
ice
min
debri
pellet
min
supernat
contain
cellular
viral
rna
separ
two
aliquot
store
supemat
blot
nylon
membran
nytran
schleicher
schuell
use
slotblot
apparatu
schleicher
schuell
mini
fold
ii
slotblot
system
rna
collect
denatur
mix
l
x
ssc
nacl
sodium
citrat
ph
formaldehyd
te
ph
heat
min
fifti
rna
load
well
slot
blot
apparatu
vacuum
blot
rins
x
ssc
air
dri
bake
vacuum
hour
probe
p
label
kb
gene
cdna
hour
presenc
formamid
fisher
scientif
describ
sambrook
et
al
blot
expos
day
kodak
xomat
ar
radiograph
film
result
shown
tabl
basal
level
synthetas
activ
found
untreat
cell
treatment
unitsml
unitsml
ifn
result
signific
increas
synthetas
activ
rel
untreat
cell
p
increas
synthetas
activ
respons
unitml
ifn
signific
p
viru
yield
given
tabl
hpi
viru
titr
supernat
similar
ifntreat
viru
control
well
hpi
viru
titr
ifntreat
cell
significantli
lower
pi
untreat
cell
reduct
approxim
log
pfuml
appreci
differ
viru
titr
cell
treat
unitsml
ifn
viru
yield
radiolabel
experi
tabl
alway
significantli
lower
pi
cultur
treat
ifn
untreat
cultur
reduct
viru
yield
associ
ifn
treatment
greatest
hour
period
yield
reduct
log
pfuml
cell
treat
unitsml
ifn
hour
period
yield
reduct
remain
log
pfuml
cell
treat
unitsml
ifn
declin
log
pfuml
unitsml
ifn
hour
label
period
reduct
viru
yield
declin
log
pfuml
cell
treat
unitsml
ifn
respect
page
whole
cell
lysat
fig
show
differ
cell
control
viru
control
ifn
treat
cell
viru
control
lane
b
f
j
protein
slightli
kda
probabl
n
protein
tgev
seen
intens
band
increas
hour
label
period
cell
treat
unitsml
ifn
band
visibl
hour
lane
c
g
becam
evid
cell
treat
unitsml
ifn
hour
label
period
lane
k
l
never
intens
ifntreat
cell
viru
control
cell
band
detect
cell
control
sampl
lane
e
page
immunoprecipit
radiolabel
sampl
shown
fig
protein
approxim
kda
evid
viru
control
lane
b
f
j
band
increas
intens
later
radiolabel
period
also
present
though
much
lower
intens
ifntreat
cell
lane
c
g
h
k
l
intens
band
decreas
increas
ifn
concentr
band
present
cell
control
lane
e
kda
protein
probabl
n
protein
faintli
visibl
lane
k
l
viru
yield
supernat
cultur
use
rna
extract
shown
tabl
hpi
viru
yield
viru
control
ifn
treat
cell
approxim
hpi
viru
titr
increas
similar
amount
viru
control
cell
treat
unitsml
ifn
viru
titr
continu
increas
hpi
sampl
collect
hour
howev
viru
yield
cell
treat
unitsml
ifn
approxim
log
pfuml
less
viru
control
cell
treat
unitsml
ifn
result
rnadna
hybrid
shown
fig
viru
specif
rna
detect
hpi
sampl
intens
hybrid
increas
studi
treatment
st
cell
recombin
human
unalpha
shown
increas
activ
synthetas
cell
abil
heterolog
ifn
induc
synthetas
porcin
cell
demonstr
previous
bosworth
maclachlan
note
similar
effect
recombin
bovin
ifnalpha
primari
swine
testi
kidney
cell
studi
st
cell
activ
synthetas
similar
cell
treat
either
unitsml
ifn
suggest
maximum
synthetas
activ
may
induc
rel
low
amount
ifn
howev
mark
differ
reduct
viru
yield
obtain
unitsml
versu
unitsml
ifn
experi
product
tgev
protein
rna
ifn
treat
cell
indic
rna
product
littl
affect
unitsml
ifn
decreas
unitsml
ifn
protein
product
decreas
unitsml
ifn
propos
mechan
action
synthetas
activ
latent
ribonucleas
degrad
viral
rna
particularli
mrna
lead
decreas
viral
protein
product
samuel
chebath
revel
sen
ransohoff
result
indic
viral
protein
product
may
decreas
without
appar
decreas
rna
product
suggest
synthetas
may
signific
factor
reduct
tgev
yield
ifntreat
st
cell
reduct
viru
yield
lower
report
previous
ifn
prepar
st
cell
jordan
derbyshir
probabl
higher
moi
use
present
studi
protein
radiolabel
experi
reduct
viru
yield
seem
correspond
reduct
protein
yield
examin
lysat
infect
cell
page
reveal
protein
approxim
kda
correspond
n
protein
tgev
saif
heckert
addit
page
immunoprecipit
infect
cell
reveal
protein
approxim
kda
correspond
protein
tgev
saif
heckert
failur
immunoprecipit
procedur
detect
tgev
n
protein
probabl
due
use
antiserum
rais
heterolog
strain
tgev
sinc
vaughn
paul
found
antisera
use
precipit
nonhomolog
strain
tgev
effici
precipit
protein
n
case
protein
viru
intens
protein
band
obtain
page
cell
lysat
immunoprecipit
indic
reduct
viru
protein
product
ifntreat
cell
extent
reduct
appear
relat
concentr
ifn
greatest
cell
treat
unitsml
ifn
effect
consist
whole
cell
lysat
immunoprecipit
protein
label
period
also
consist
viru
yield
correspond
cultur
supemat
evid
decreas
viral
rna
synthesi
found
time
hpi
cell
treat
unitsml
ifn
hybrid
made
probe
capabl
detect
plu
minu
sens
rna
tgev
gene
therefor
genom
rna
tgev
sgene
mrna
complementari
minu
strand
would
detect
proport
total
rna
neg
sens
probabl
small
sawicki
sawicki
hpi
like
primari
rna
speci
tgev
sgene
mrna
ratio
genom
length
rna
mrna
would
increas
cours
infect
keck
et
al
reduct
viru
protein
product
may
aris
decreas
mrna
product
decreas
translat
viral
specif
mrna
present
result
indic
tgev
protein
product
sensit
rna
accumul
antivir
state
induc
ifn
decreas
lower
concentr
ifn
significantli
reduc
rna
accumul
result
support
conclus
decreas
tgev
protein
synthesi
primarili
due
decreas
viral
rna
accumul
rather
result
decreas
translat
viral
rna
conclus
data
discuss
suggest
synthetas
system
play
signific
role
observ
decreas
viral
protein
product
like
therefor
ifninduc
antivir
state
tgev
mediat
primarili
anoth
mechan
perhap
pl
kinas
system
known
inhibit
translat
samuel
decreas
accumul
viral
rna
observ
experi
may
due
decreas
transcript
increaseddestructionof
transcript
latter
mechan
may
mediat
synthetas
system
activ
ribonucleas
howev
shown
ongo
protein
synthesi
necessari
coronavir
rna
synthesi
mahi
et
al
sawicki
sawicki
decreas
product
viral
rnadepend
rna
polymeras
may
reduc
coronavir
rna
synthesi
therefor
reduct
viral
protein
synthesi
may
also
involv
decreas
accumul
viral
rna
